Optional early redemption of preferred securities

RNS Number : 3178W
Banco Santander S.A.
16 April 2019
 

 

 

 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

 

INSIDE INFORMATION

 

Banco Santander, S.A. (the "Issuer" or "Banco Santander") announces its decision to carry out the optional early redemption of all outstanding Series II/2014 Non-Step-Up Non-Cumulative Contingent Convertible Perpetual Preferred Tier 1 Securities, with a nominal total value of USD 1,500,000,000, with ISIN code XS1066553329 and common code 106655332, which are traded on the Global Exchange Market of the Irish Stock Exchange (the "CoCos").

 

The redemption of all of the outstanding CoCos, which has been authorised by the European Central Bank, will be carried out on the First Determination Date falling on 19 May 2019 (the "First Determination Date"), pursuant to Conditions of the Preferred Securities of the relevant prospectus of the CoCos (Offering Circular dated 9 May 2014) (the "Terms and Conditions"). The decision of the Issuer to exercise the optional early redemption right is irrevocable, and holders of the CoCos are being informed by means of this material fact announcement and other foreseen notices, in the form, within the required timeframe, and for the purposes set out in Conditions 6 and 11 of the Terms and Conditions.

 

The early redemption price, which will be equal to the outstanding nominal value (liquidation preference in the terminology of the prospectus) of each CoCo plus any accrued and unpaid distribution associated to each CoCo up to (but excluding) the First Determination Date, will be paid to the holders of the Preferred Securities by the Principal Paying Agent, in accordance with the Terms and Conditions, on 20 May 2019.

 

 

Boadilla del Monte (Madrid), April 16th, 2019

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKLKFDLNEEF
UK 100